Does TRICHLORMETHIAZIDE Cause Bronchial secretion retention? 97 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Bronchial secretion retention have been filed in association with TRICHLORMETHIAZIDE. This represents 28.4% of all adverse event reports for TRICHLORMETHIAZIDE.
97
Reports of Bronchial secretion retention with TRICHLORMETHIAZIDE
28.4%
of all TRICHLORMETHIAZIDE reports
0
Deaths
97
Hospitalizations
How Dangerous Is Bronchial secretion retention From TRICHLORMETHIAZIDE?
Of the 97 reports, 97 (100.0%) required hospitalization.
Is Bronchial secretion retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRICHLORMETHIAZIDE. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does TRICHLORMETHIAZIDE Cause?
Dyspnoea (105)
Cough (104)
Drug ineffective (103)
Obstructive airways disorder (103)
Pneumonia (101)
Eosinophil count increased (97)
Multiple allergies (97)
Pulmonary mass (97)
Sputum culture positive (97)
Upper-airway cough syndrome (97)
What Other Drugs Cause Bronchial secretion retention?
ALBUTEROL (374)
TIOTROPIUM (295)
PREDNISONE (268)
MONTELUKAST (240)
MEPOLIZUMAB (209)
BUDESONIDE (182)
OMALIZUMAB (171)
FUROSEMIDE (169)
BISOPROLOL (163)
BUDESONIDE\FORMOTEROL (156)
Which TRICHLORMETHIAZIDE Alternatives Have Lower Bronchial secretion retention Risk?
TRICHLORMETHIAZIDE vs TRICLOSAN
TRICHLORMETHIAZIDE vs TRIENTINE
TRICHLORMETHIAZIDE vs TRIENTINE TETRAHYDROCHLORIDE
TRICHLORMETHIAZIDE vs TRIFAROTENE
TRICHLORMETHIAZIDE vs TRIFLUOPERAZINE